Chk2 Inhibitor for Recurrent EpitheliAl periToneal, fallopIan or oVarian cancEr (CREATIVE Phase IA Trial)

Clinical trial NCT04678102 · UNKNOWN

Trial details

NCT number: NCT04678102
Sponsor: Seoul National University Hospital
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Platinum-resistant Ovarian Cancer Platinum-refractory Ovarian Carcinoma Platinum-Resistant Fallopian Tube Carcinoma Platinum-Resistant Primary Peritoneal Carcinoma

Start date: 2020-12-17
Primary completion: 2023-12-31
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.